Provided by the Annenberg Center for Health Sciences at Eisenhower
This activity is supported by an independent educational grant from Pfizer.
Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale for targeting Janus kinase (JAK)-STAT signaling pathways, faculty discuss the clinical implications of new research for patients with IBD.
This activity was developed for gastroenterologists, gastroenterology fellows, and other health care providers who manage patients with inflammatory bowel disease.
At the conclusion of this activity, participants should be better able to:
Describe the relationship between the Janus Kinase-STAT signaling pathway and pathogenesis of inflammatory bowel disease
Summarize the latest research developments in treatment of inflammatory bowel disease with Janus Kinase (JAK) inhibitors
Incorporate evidence-based research into clinical practice
Conflict Of Interest Disclosure Policy
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
Russell D. Cohen, MD Professor of Medicine, Pritzker School of Medicine Director, Inflammatory Bowel Disease Center Co-Director, Advanced IBD Fellowship Program The University of Chicago Medicine Chicago, Illinois
Thomas A. Ullman, MD Senior Associate Dean for Clinical Affairs Professor of Medicine The Dr. Henry D. Janowitz Division of Gastroenterology Chief Medical Officer Mount Sinai Doctors Faculty Practice Icahn School of Medicine at Mount Sinai New York, New York
Dr. Ullman discloses the following: Consultant: American Regent
Planners and Managers Disclosures
Annenberg Center for Health Sciences John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Additional content planners The following have no significant relationship to disclose: Eugene A. Cullen, MD (peer reviewer) Alexandra Howson, PhD (medical writer)
AMA PRA Category 1 Credit(s)TM
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.
Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.
For help or questions about this Internet activity, please contact Annenberg Continuing Education: email@example.com Annenberg Center for Health Sciences 39000 Bob Hope Drive Dinah Shore Building Rancho Mirage, CA 92270 Phone: 760-773-4500 Fax: 760-773-4513 8 AM – 5 PM, Pacific Time, Monday – Friday
Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/